Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
Yu-Ling Tseng, Po-Chao Lu, Chi-Chang Lee, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Characteristic roadmap of linker governs the rational design of PROTACs
Yawen Dong, Tingting Ma, Ting Xu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4266-4295
Open Access | Times Cited: 20
Journey of PROTAC: From Bench to Clinical Trial and Beyond
Kyli Berkley, Julian Zalejski, Nidhi Sharma, et al.
Biochemistry (2025)
Closed Access | Times Cited: 2
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Maria Tsekrekou, Maria Giannakou, Katerina Papanikolopoulou, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 8
Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?
Sandra Kuemper, Andrew G. Cairns, Kristian Birchall, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Breaking Bad Proteins—Discovery Approaches and the Road to Clinic for Degraders
Corentin Bouvier, Rachel Lawrence, Francesca Cavallo, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 578-578
Open Access | Times Cited: 5
Research progress of PROTACs for neurodegenerative diseases therapy
Zhifang Cai, Zunhua Yang, Huilan Li, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107386-107386
Closed Access | Times Cited: 5
C9ORF72 poly-PR induces TDP-43 nuclear condensation via NEAT1 and is modulated by HSP70 activity
Diksha Agnihotri, Chi-Chang Lee, Po-Chao Lu, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115173-115173
Closed Access
Graphene Quantum Dots Attenuate TDP-43 Proteinopathy in Amyotrophic Lateral Sclerosis
Na-Young Park, Yunseok Heo, Ji Won Yang, et al.
ACS Nano (2025)
Closed Access
Proteolytic therapeutic modalities for amyloidoses: Insights into immunotherapy, PROTAC, and photo-oxygenation
Mai Kuriyama, C Wang, Takahide Nagase, et al.
Neurotherapeutics (2025), pp. e00548-e00548
Open Access
Advancements in PROTAC-based therapies for neurodegenerative diseases
Deyuan Kong, Liying Meng, Pengfei Lin, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Proteostasis in neurodegenerative diseases
Sumit Kinger, Yuvraj Anandrao Jagtap, Prashant Kumar, et al.
Advances in clinical chemistry (2024), pp. 270-333
Closed Access | Times Cited: 4
Central Nervous System Targeted Protein Degraders
Bedwyr ab Ion Thomas, H Lewis, D. Heulyn Jones, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1164-1164
Open Access | Times Cited: 11
Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Randall J. Eck, Jade G. Stair, Brian C. Kraemer, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 3
Proximity-Induced Pharmacology for Amyloid-Related Diseases
Andrea Bertran-Mostazo, Gabrielė Putriūtė, Irene Álvarez-Berbel, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 449-449
Open Access | Times Cited: 3
Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update
Léa Lescouzères, Scott B. Patten
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1213-1233
Open Access | Times Cited: 2
Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases
Y. Wu, Biao Ma, Chang Yu Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10187-10187
Open Access | Times Cited: 2
Effective Inhibition of TDP‐43 Aggregation by Native State Stabilization
Lixin Yang, Yllza Jasiqi, Agnès Zettor, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 7
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells
Patrick J. Brennan, Rebecca E. Saunders, Mary Spanou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Aberrant protein aggregation in amyotrophic lateral sclerosis
Huaixiu Wang, Rong Zeng
Journal of Neurology (2024) Vol. 271, Iss. 8, pp. 4826-4851
Closed Access | Times Cited: 1
CUTS RNA Biosensor for the Real-Time Detection of TDP-43 Loss-of-Function
Longxin Xie, Jessica Merjane, Cristian A Bergmann, et al.
(2024)
Open Access | Times Cited: 1
Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
Mengyao Wu, Yilan Zhao, Chi Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28502-28530
Closed Access | Times Cited: 1
Effective Inhibition of TDP‐43 Aggregation by Native State Stabilization
Lixin Yang, Yllza Jasiqi, Agnès Zettor, et al.
Angewandte Chemie (2023) Vol. 136, Iss. 3
Open Access | Times Cited: 2
CUTS RNA Biosensor for the Real-Time Detection of TDP-43 Loss-of-Function
Longxin Xie, Jessica Merjane, Cristian A Bergmann, et al.
(2024)
Open Access
CUTS RNA Biosensor for the Real-Time Detection of TDP-43 Loss-of-Function
Longxin Xie, Jessica Merjane, Cristian A Bergmann, et al.
(2024)
Open Access
Page 1 - Next Page

Scroll to top